BR9507960B1 - processos e kits para deteção de resistência à rifampicina e/ou rifabutina de espécies de mycobacterium. - Google Patents

processos e kits para deteção de resistência à rifampicina e/ou rifabutina de espécies de mycobacterium.

Info

Publication number
BR9507960B1
BR9507960B1 BRPI9507960-2A BR9507960A BR9507960B1 BR 9507960 B1 BR9507960 B1 BR 9507960B1 BR 9507960 A BR9507960 A BR 9507960A BR 9507960 B1 BR9507960 B1 BR 9507960B1
Authority
BR
Brazil
Prior art keywords
sample
detection
antibiotic resistance
mycobacterium species
mycobacterium
Prior art date
Application number
BRPI9507960-2A
Other languages
English (en)
Other versions
BR9507960B8 (pt
BR9507960A (pt
Inventor
Beenhouwer Hans De
Francoise Portaels
Lieve Machtelinckx
Geert Jannes
Rudi Rossau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8218646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9507960(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BR9507960A publication Critical patent/BR9507960A/pt
Publication of BR9507960B1 publication Critical patent/BR9507960B1/pt
Publication of BR9507960B8 publication Critical patent/BR9507960B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
BRPI9507960-2B8A 1994-06-09 1995-06-09 Processos e kits para deteção de resistência à rifampicina e/ou rifabutina de espécies de mycobacterium. BR9507960B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94870093 1994-06-09
PCT/EP1995/002230 WO1995033851A2 (en) 1994-06-09 1995-06-09 Method for the detection of the antibiotic resistance spectrum of mycobacterium species

Publications (3)

Publication Number Publication Date
BR9507960A BR9507960A (pt) 1997-09-02
BR9507960B1 true BR9507960B1 (pt) 2010-08-10
BR9507960B8 BR9507960B8 (pt) 2014-09-30

Family

ID=8218646

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9507960-2B8A BR9507960B8 (pt) 1994-06-09 1995-06-09 Processos e kits para deteção de resistência à rifampicina e/ou rifabutina de espécies de mycobacterium.

Country Status (14)

Country Link
US (4) US6329138B1 (pt)
EP (1) EP0771360B1 (pt)
JP (1) JP4558105B2 (pt)
AT (1) ATE261496T1 (pt)
AU (1) AU703947B2 (pt)
BR (1) BR9507960B8 (pt)
CA (1) CA2192364C (pt)
CZ (1) CZ298020B6 (pt)
DE (1) DE69532675T2 (pt)
DK (1) DK0771360T3 (pt)
ES (1) ES2217280T3 (pt)
PT (1) PT771360E (pt)
RU (1) RU2204608C2 (pt)
WO (1) WO1995033851A2 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9507960B8 (pt) * 1994-06-09 2014-09-30 Fujirebio Europ N V Processos e kits para deteção de resistência à rifampicina e/ou rifabutina de espécies de mycobacterium.
CA2284775C (en) 1997-04-15 2006-11-07 Ciba Specialty Chemicals Holding Inc. Preparation of low-dust stabilisers
DE19734940A1 (de) * 1997-08-12 1999-02-18 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Nucleinsäuremolekül-Satz für Salmonella-Nachweis, Nucleinsäuren, Kit und Verwendung
US7108968B2 (en) * 1998-04-03 2006-09-19 Affymetrix, Inc. Mycobacterial rpoB sequences
JP2002532103A (ja) * 1998-12-11 2002-10-02 ビジブル ジェネティクス インコーポレイテッド マイコバクテリウムツバキュロシスにおける抗生物質耐性変異の特徴付けのための方法及びキット
EP1076099A3 (en) * 1999-08-03 2003-03-05 Nisshinbo Industries, Inc. Kit for diagnosis of tubercle bacilli
KR100363615B1 (ko) * 1999-10-27 2002-12-06 주식회사 제니스라이프사이언스 ｒｐｏＢ 유전자 단편 및 이를 이용한 결핵균과 비결핵마이코박테리아의 동정방법
EP1307587A2 (en) 2000-03-03 2003-05-07 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES MULTIPLEX HYBRIDIZATION SYSTEM FOR IDENTIFICATION OF PATHOGENIC i MYCOBACTERIUM /i AND METHOD OF USE
KR100451108B1 (ko) * 2000-05-30 2004-10-06 주식회사 바이오메드랩 마이코박테리아 균동정 및 약제내성 탐지를 위한 유전자진단키트 및 그 키트의 제조방법
AP2002002454A0 (en) * 2000-06-28 2002-06-30 Bakulesh Mafatlal Khamar Agents for reversal of drug resistance in mycobacterium tuberculosis.
US6902894B2 (en) * 2001-09-07 2005-06-07 Genetel Pharmaceuticals Ltd. Mutation detection on RNA polmerase beta subunit gene having rifampin resistance
US7094542B2 (en) * 2001-09-18 2006-08-22 Gen-Probe Incorporated Detection of rpoB sequences of Mycobacterium tuberculosis
WO2003025227A1 (en) * 2001-09-18 2003-03-27 Gen-Probe Incorporated Detection of rpob sequences of mycobacterium tuberculosis
KR100454585B1 (ko) * 2001-10-09 2004-11-02 주식회사 에스제이하이테크 마이코박테리아의 균주 감별, 결핵균의 스트레인 감별과항생제 내성을 검출하기 위한 프로브를 포함하는마이크로어레이와 이를 이용한 검출 방법 및 진단 키트
FI115637B (fi) * 2003-12-19 2005-06-15 Mobidiag Oy Diagnostinen menetelmä hengitystieinfektioita aiheuttavien bakteerien osoittamiseksi ja tunnistamiseksi ja menetelmässä käyttökelpoinen alukeseos
GB0403039D0 (en) * 2004-02-11 2004-03-17 Health Prot Agency TB resistance assay
US7445895B2 (en) * 2004-04-28 2008-11-04 Asiagen Corporation Methods, kits and assay system for detecting drug-resistant Mycobacterium tuberculosis
ITRM20050067A1 (it) * 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine.
ITRM20050068A1 (it) * 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine.
US7914982B2 (en) * 2005-02-17 2011-03-29 Trovagene, Inc. Methods for detecting pathogen specific nucleic acids in urine
RU2376387C2 (ru) * 2005-12-26 2009-12-20 Учреждение Российской академии наук Институт молекулярной биологии им. В.А. Энгельгардта РАН Способ одновременного обнаружения микобактерий туберкулезного комплекса и идентификации мутаций в днк микобактерий, приводящих к устойчивости микроорганизмов к рифампицину и изониазиду, на биологических микрочипах, набор праймеров, биочип и набор олигонуклеотидных зондов, используемые в способе
EP1992703B1 (en) * 2006-03-13 2012-04-11 Wako Pure Chemical Industries, Ltd. Method for detection of mutant gene
PL2195450T3 (pl) * 2007-08-22 2013-09-30 Trovagene Inc Sposób zastosowania miRNA do wykrywania in vivo śmierci komórki
US7946758B2 (en) * 2008-01-31 2011-05-24 WIMM Labs Modular movement that is fully functional standalone and interchangeable in other portable devices
JP2009189283A (ja) * 2008-02-13 2009-08-27 Nipro Corp 結核菌および非結核性抗酸菌検出試薬
KR101001368B1 (ko) * 2008-05-22 2010-12-14 엠앤디 (주) 나균 리팜핀 내성 진단용 프로브 및 그 키트
KR100990756B1 (ko) 2008-05-22 2010-10-29 엠앤디 (주) 결핵균 약제 내성 진단용 프로브 및 그 키트
ES2689257T3 (es) 2010-11-10 2018-11-12 Brandeis University Kit para la detección e identificación de micobacterias
TWI614345B (zh) * 2012-06-22 2018-02-11 Taichung Veterans General Hospital 檢測數種非結核分枝桿菌、結核分枝桿菌及其抗藥性之探針、晶片、套組與方法
RU2552214C2 (ru) * 2013-04-03 2015-06-10 Федеральное Государственное Бюджетное Учреждение науки Институт химический биологии и фундаментальной медицины Сибирского отделения РАН (ИХБФМ СО РАН) СПОСОБ ВЫЯВЛЕНИЯ УСТОЙЧИВЫХ К ПИРАЗИНАМИНУ ИЗОЛЯТОВ Mycobacterium tuberculosis
KR101472993B1 (ko) * 2013-08-20 2014-12-18 한국생명공학연구원 마이크로박테리움 속 hy-17 균주로부터 생산되는 신규한 알카리 내성 글리코시드 하이드로레이즈 패밀리 10 자일라나제
CN116042880A (zh) 2014-10-10 2023-05-02 新泽西鲁特格斯州立大学 结核分枝杆菌的聚合酶链反应引物和探针
EP3310929A2 (en) * 2015-06-19 2018-04-25 Cambridge Enterprise Limited Diagnosis and treatment of infectious disease
WO2018026141A1 (ko) * 2016-08-04 2018-02-08 주식회사 옵티팜 퀀타매트릭스 어세이 플랫폼 기반 결핵 및 비결핵 항산균의 검출 및 동정과 결핵균의 리팜핀 내성여부를 동시 확인할 수 있는 진단법 및 그 키트
RU2659958C2 (ru) * 2016-10-17 2018-07-04 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ФПИ" Минздрава России) Способ оценки лекарственной чувствительности Mycobacnerium tuberculosis на основе результатов определения иммунологических показателей крови у больного туберкулезом легких человека
WO2020096858A1 (en) * 2018-11-09 2020-05-14 Longhorn Vaccines And Diagnostics, Llc Rapid pcr methodology

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775361A (en) * 1986-04-10 1988-10-04 The General Hospital Corporation Controlled removal of human stratum corneum by pulsed laser to enhance percutaneous transport
ATE163680T1 (de) * 1986-11-24 1998-03-15 Gen Probe Inc Nukleinsäuresonden zum nachweis und/oder zur quantifizierung von nicht-viralen organismen
WO1989006555A1 (en) * 1988-01-21 1989-07-27 Massachusetts Institute Of Technology Transport of molecules across tissue using electroporation
US5749847A (en) * 1988-01-21 1998-05-12 Massachusetts Institute Of Technology Delivery of nucleotides into organisms by electroporation
US5713845A (en) * 1991-10-29 1998-02-03 Thermolase Corporation Laser assisted drug delivery
US5423803A (en) * 1991-10-29 1995-06-13 Thermotrex Corporation Skin surface peeling process using laser
US5246436A (en) * 1991-12-18 1993-09-21 Alcon Surgical, Inc. Midinfrared laser tissue ablater
US5165418B1 (en) * 1992-03-02 1999-12-14 Nikola I Tankovich Blood sampling device and method using a laser
EP0639229B2 (en) 1992-04-30 2009-11-25 Institut Pasteur Rapid detection of antibiotic resistance in mycobacterium tuberculosis
US5851763A (en) 1992-09-17 1998-12-22 Institut Pasteur Rapid detection of antibiotic resistance in mycobacterium tuberculosis
US5633131A (en) * 1992-04-30 1997-05-27 Institut Pasteur Rapid detection of isoniazid resistance in mycobacterium tuberculosis probes for selecting nucleic acid encoding isoniazid resistance, and methods and kits
US5464386A (en) * 1992-08-17 1995-11-07 Genetronics, Inc. Transdermal drug delivery by electroincorporation of vesicles
US5462520A (en) * 1992-08-17 1995-10-31 Genetronics, Inc. Transsurface drug delivery by electrofusion of microbubbles to the tissue surface
US5643252A (en) * 1992-10-28 1997-07-01 Venisect, Inc. Laser perforator
US5462743A (en) * 1992-10-30 1995-10-31 Medipro Sciences Limited Substance transfer system for topical application
US5458140A (en) * 1993-11-15 1995-10-17 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
US5556612A (en) * 1994-03-15 1996-09-17 The General Hospital Corporation Methods for phototherapeutic treatment of proliferative skin diseases
US5505726A (en) * 1994-03-21 1996-04-09 Dusa Pharmaceuticals, Inc. Article of manufacture for the photodynamic therapy of dermal lesion
US5643723A (en) 1994-05-26 1997-07-01 Roche Molecular Systems, Inc. Detection of a genetic locus encoding resistance to rifampin in mycobacterial cultures and in clinical specimens
BR9507960B8 (pt) 1994-06-09 2014-09-30 Fujirebio Europ N V Processos e kits para deteção de resistência à rifampicina e/ou rifabutina de espécies de mycobacterium.
US5554153A (en) * 1994-08-29 1996-09-10 Cell Robotics, Inc. Laser skin perforator

Also Published As

Publication number Publication date
AU2789695A (en) 1996-01-04
DE69532675D1 (de) 2004-04-15
US7252936B2 (en) 2007-08-07
WO1995033851A2 (en) 1995-12-14
BR9507960B8 (pt) 2014-09-30
EP0771360A1 (en) 1997-05-07
JP4558105B2 (ja) 2010-10-06
DK0771360T3 (da) 2004-07-12
AU703947B2 (en) 1999-04-01
ATE261496T1 (de) 2004-03-15
PT771360E (pt) 2004-07-30
US6329138B1 (en) 2001-12-11
CA2192364C (en) 2009-01-20
EP0771360B1 (en) 2004-03-10
RU2204608C2 (ru) 2003-05-20
WO1995033851A3 (en) 1996-02-08
JPH10500857A (ja) 1998-01-27
CZ361296A3 (en) 1997-07-16
ES2217280T3 (es) 2004-11-01
US20030152982A1 (en) 2003-08-14
DE69532675T2 (de) 2005-02-24
US20090068651A1 (en) 2009-03-12
CA2192364A1 (en) 1995-12-14
CZ298020B6 (cs) 2007-05-23
US6632607B1 (en) 2003-10-14
BR9507960A (pt) 1997-09-02

Similar Documents

Publication Publication Date Title
BR9507960B8 (pt) Processos e kits para deteção de resistência à rifampicina e/ou rifabutina de espécies de mycobacterium.
HK1037687A1 (en) Simultaneous detection, identification and differentiation of mycobacterium species using a hybridization assay
EP0228075A3 (en) Eucaryotic genomic dna dot-blot hybridization method
CA2217325A1 (en) Nucleic acid detection and amplification by chemical linkage of oligonucleotides
PL278176A1 (en) Method of detecting sequences of nucleotides and sets for carrying out diagnostic tests
EP2322670A3 (en) Method for typing and detecting HBV
CA2059657A1 (fr) Procede de detection d'une sequence nucleotidique selon la technique d'hybridation sandwich
WO2001049883A3 (en) Amplification based polymorphism detection
CA2155387A1 (en) Species-Specific Detection of Mycobacterium Kansasii
CA2075037A1 (en) Methods and reagents for hla drbeta dna typing
EP2302075A3 (en) Method for typing of HLA alleles
DK0689609T3 (da) Fremgangsmåde til typisering af HLA-B under anvendelse af specifikke primere og probesæt
BR0014017A (pt) Método para detectar alterações em um gene através de pcr de ampla abrangência usando elementos humanos móveis
DK0966545T3 (da) Fremgangsmåde til typebestemmelse af minor histokompatibilitetsantigen HA-1
WO1998000565A3 (en) NUCLEIC ACID PRIMERS AND PROBES FOR DETECTING $i(MYCOPLASMA PNEUMONIAE)
Chen et al. A polymerase chain reaction-sequence-specific oligonucleotide procedure for HLA class II typing using biotin-and digoxigenin-labeled probes simultaneously in hybridization
Woolford et al. Simplified procedures for detection of amplified DNA using fluorescent label incorporation and reverse probing
WO2001075173A3 (en) β 2 ADRENERGIC POLYMORPHISM DETECTION
CA2211165A1 (en) Methods for sensitive detection of reverse transcriptase

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: A REQUERENTE DEVERA COMPLEMENTAR A TAXA RELATIVA A 6 (SEIS) REIVINDICACOES EXCEDENTES.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: COMO A REQUERENTE NAO APRESENTOU ARGUMENTOS TECNICOS CONSIDERADOS PERTINENTES, DE ACORDO COM O ARTIGO 37, SUGIRO O INDEFERIMENTO DO PRESENTE PEDIDO, TENDO POR BASE O ARTIGO 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/08/2010, OBSERVADAS AS CONDICOES LEGAIS.

B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: COMPLEMENTAR A RETRIBUICAO DA 16A ANUIDADE DE ACORDO COM A TABELA VIGENTE, REFERENTE A GUIA DE RECOLHIMENTO 921004074815.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.5 NA RPI 2183 DE 06/11/2012.

B24B Patent annual fee: requirement for complementing annual fee

Free format text: COMPLEMENTAR A RETRIBUICAO DA 16A ANUIDADE DE ACORDO COM A TABELA VIGENTE, REFERENTE A GUA DE RECOLHIMENTO 921004074815.

B24D Patent annual fee: restoration after fee payment
B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.061587/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132263-70.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: GILEAD SCIENCES, INC, HRISSANTHI IKONOMIDOU, INNOGENETICS N.V., ISTITUTO NAZIONALE PRE LO STUDIO E LA, CURA DEI TUMORI, ITALFARMACO S.P.A.

B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI-0132263-70.2013.4.02.5101 SECAO JUDICIARIA DO RIO DE JANEIRO-13A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO52400.061587/2013-47 AUTOR:INPI-INSTITUTO NACIONAL DE PROPRIEDADE INDUSTRIAL REU(S):GILEAD SCIENCES INC.,HRISSANTHI IKONOMIDOU, INNOGENTICS NV, ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI E ITALFARMACO SPA DECISAO:HOMOLOGO O ACORDO FIRMADO PELAS PARTES JULGANDO EXTINTO O PROCESSO COM RESOLUCAO DE MERITO, FORTE NO ART.269, III DO CODIGO DE PROCESSO CIVIL.

B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI-52400.106352/14 SECAO JUDICIARIA DO RIO DE JANEIRO -13A VARA FEDERAL PROCESSO NO. 0132263-70.2013.4.02.5101 AUTOR: INPI-INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL REU: INNOGENETICS N.V DECISAO: DESMEMBRAMENTOS NO 0001853-84.2014.4.025101 EM NOME DA RE INNOGENETICS N.V. E PARA A PARTE GILEAD SCIENCES INC., MANTIDAS NO POLO PASSIVO DOS PRESENTES AUTOS AS EMPRESAS HRISSANTHI IKONOMIDOU, ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI E ITALFARMACOS SPA.

B19B Notification of judicial decision: publication cancelled

Free format text: REFERENTE A NOTIFICACAO DO DESPACHO 19.1 NA PATENTE PI9507960-2, RPI 2257 DE 08.04.2014.

B25D Requested change of name of applicant approved

Owner name: FUJIREBIO EUROPE N.V. (BE)

B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI-52400.106352/2014 SECAO JUDICIARIA DO RIO DE JANEIRO 13A VARA FEDERAL PROCESSO NO 2014.51.01.001853-8 AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL INPI REU(S): INNOGENETICS NV DECISAO: ANTE TODO O EXPOSTO, JULGO PARCIALMENTE PROCEDENTE A PRETENSAO DO INPI EM RELACAO A EMPRESA INNOGENETICS NV, RESOLVENDO O MERITO, NOS TERMOS DO ART. 269, I, DO CPC, PARA DECRETAR A NULIDADE PARCIAL DA PATENTE PI9507960-2, APENAS NO QUE SE REFERE AO PRAZO DE VIGENCIA DA MESMA, PARA DETERMINAR A SUA READEQUACAO PARA VINTE ANOS CONTADOS A PARTIR DO RESPECTIVO DEPOSITO, NOS TERMOS DO PARAGRAFO UNICO DO ART.229 C/C O CAPUT DO ART.40 DA LPI. ANTECIPO OS EFEITOS DA TUTELA, A FIM DE DETERMINAR A IMEDI

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A RPI 2066 DE 10/08/2010, QUANTO AO PRAZO DE VALIDADE DE ACORDO COM A DECISAO DA 13A VARA DEFERAL DO RIO DE JANEIRO.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 09/06/2015